Marija Balic, Co-director of Magee Womens Cancer Program at University of Pittsburgh School of Medicine, shared a post on LinkedIn about recent paper she and colleagues co-authored:
“Happy to share, liquid biopsy testing is not easily available for breast cancer patients around the world.
One way to make sure women with metastatic hormone receptor positive cancer get tested in controlled way.”
Title: Clinical impact of single-gene vs. panel sequencing in advanced HR + /HER2− breast cancer: insights and implications
Authors: Eva Valentina Klocker, Nina Dobrić, Ricarda Graf, Christine Beichler, Dominik Hlauschek, Christoph Suppan, Lara Pancheri, Daniel Egle, Carmen Albertini, Rupert Bartsch, Angelika Martina Starzer, Philipp Jakob Jost, Gabriel Rinnerthaler, Ellen Heitzer, Nadia Dandachi, Marija Balic
Read The Full Article at NPJ Breast Cancer.
More Posts Featuring Breast Cancer.